Klotho Neurosciences
$0.54
6
+$0.02+4.44% Thursday 20:00
Statistics
Day High
0.58
Day Low
0.52
52W High
13.1
52W Low
0.51
Volume
61,566
Avg. Volume
1,739,206
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-
People Also Follow
This list is based on the watchlists of people on Stock Events who follow KLTO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.
Show more...
CEO
Employees
1
Country
US
ISIN
US49876K1034